See how VitalScan ANS+ is transforming practices across cardiology, podiatry, and primary care — with measurable revenue growth and earlier clinical detection.
A 4-physician cardiology group needed objective autonomic data for post-MI patients and those with suspected Cardiac Autonomic Neuropathy (CAN). Standard ECG and stress testing didn't capture autonomic dysfunction.
Implemented VitalScan ANS+ as a routine screening for all diabetic and post-MI patients. The 15-minute test was administered by existing clinical staff during regular office visits.
"VitalScan gives us objective autonomic data we simply couldn't get before. We're identifying at-risk patients years earlier than we could with standard testing."
— Practice Director
A busy podiatry practice serving a large diabetic population needed earlier detection of peripheral and small fiber neuropathy. Standard monofilament testing was catching nerve damage too late — after foot complications had already begun.
Added SudoCheck sudomotor testing as part of every diabetic foot exam. The 3-minute test detected sudomotor dysfunction in patients who had no clinical symptoms yet.
"We're now catching nerve damage years before symptoms appear. That means earlier intervention, better outcomes, and fewer foot complications down the road."
— Lead Podiatrist
A family medicine practice in a competitive market was looking for a way to differentiate its services and increase revenue per visit. Standard annual physicals weren't capturing early autonomic and vascular dysfunction.
Offered VitalScan ANS+ as a proactive health assessment add-on during annual wellness visits. The 15-minute test provided patients with objective autonomic and vascular data they couldn't get at other primary care practices.
"Our patients love it. They're getting a proactive health assessment that goes beyond blood pressure and cholesterol. It's become a real differentiator in our market."
— Practice Owner
Get a personalized ROI analysis based on your patient volume and specialty.